BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12190148)

  • 1. NASH-related liver failure: one hit too many?
    Day CP
    Am J Gastroenterol; 2002 Aug; 97(8):1872-4. PubMed ID: 12190148
    [No Abstract]   [Full Text] [Related]  

  • 2. Subacute liver failure in obese women.
    Caldwell SH; Hespenheide EE
    Am J Gastroenterol; 2002 Aug; 97(8):2058-62. PubMed ID: 12190177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [NASH -- nonalcoholic steatohepatitis].
    Blechacz B; Stremmel W
    Z Gastroenterol; 2003 Jan; 41(1):77-90. PubMed ID: 12541180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver failure caused by non-alcoholic steatohepatitis in an obese young male.
    Suzuki D; Hashimoto E; Kaneda K; Tokushige K; Shiratori K
    J Gastroenterol Hepatol; 2005 Feb; 20(2):327-9. PubMed ID: 15683446
    [No Abstract]   [Full Text] [Related]  

  • 5. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C.
    Sanyal AJ; Banas C; Sargeant C; Luketic VA; Sterling RK; Stravitz RT; Shiffman ML; Heuman D; Coterrell A; Fisher RA; Contos MJ; Mills AS
    Hepatology; 2006 Apr; 43(4):682-9. PubMed ID: 16502396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of nonalcoholic steatohepatitis.
    Liou I; Kowdley KV
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S11-6. PubMed ID: 16540761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: Caldwell and Hespenheide--subacute liver failure in obese women.
    Azer SA
    Am J Gastroenterol; 2003 Jul; 98(7):1656-7; author reply 1657-8. PubMed ID: 12873600
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and pathologic risk factors for atherosclerosis in cirrhosis: a comparison between NASH-related cirrhosis and cirrhosis due to other aetiologies.
    Kadayifci A; Tan V; Ursell PC; Merriman RB; Bass NM
    J Hepatol; 2008 Oct; 49(4):595-9. PubMed ID: 18662837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with the presence of nonalcoholic steatohepatitis in patients with chronic hepatitis C.
    Solis-Herruzo JA; Pérez-Carreras M; Rivas E; Fernández-Vázquez I; Garfia C; Bernardos E; Castellano G; Colina F
    Am J Gastroenterol; 2005 May; 100(5):1091-8. PubMed ID: 15842583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease.
    McCullough AJ
    Clin Liver Dis; 2004 Aug; 8(3):521-33, viii. PubMed ID: 15331061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery.
    Beymer C; Kowdley KV; Larson A; Edmonson P; Dellinger EP; Flum DR
    Arch Surg; 2003 Nov; 138(11):1240-4. PubMed ID: 14609874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma.
    Malik SM; Gupte PA; de Vera ME; Ahmad J
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):800-6. PubMed ID: 19281869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Liver disease in obese patients].
    Giostra E; Huber O; Morel P; Hadengue A
    Rev Med Suisse; 2007 Sep; 3(123):1939-41. PubMed ID: 17918488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors predicting early postoperative liver cirrhosis-related complications after lung cancer surgery in patients with liver cirrhosis.
    Iwata T; Inoue K; Nishiyama N; Nagano K; Izumi N; Tsukioka T; Hanada S; Suehiro S
    Interact Cardiovasc Thorac Surg; 2007 Dec; 6(6):720-30. PubMed ID: 17766277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approach to the diagnosis and treatment of nonalcoholic fatty liver disease.
    Ong JP; Younossi ZM
    Clin Liver Dis; 2005 Nov; 9(4):617-34, vi. PubMed ID: 16207567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and natural history of NAFLD and NASH.
    Ong JP; Younossi ZM
    Clin Liver Dis; 2007 Feb; 11(1):1-16, vii. PubMed ID: 17544968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score.
    Huo TI; Lin HC; Lee FY; Hou MC; Lee PC; Wu JC; Chang FY; Lee SD
    Liver Int; 2006 Feb; 26(1):55-61. PubMed ID: 16420510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma.
    Cuadrado A; Orive A; García-Suárez C; Domínguez A; Fernández-Escalante JC; Crespo J; Pons-Romero F
    Obes Surg; 2005 Mar; 15(3):442-6. PubMed ID: 15826485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary liver cancers with nonalcoholic steatohepatitis.
    Hashizume H; Sato K; Takagi H; Hirokawa T; Kojima A; Sohara N; Kakizaki S; Mochida Y; Shimura T; Sunose Y; Ohwada S; Mori M
    Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):827-34. PubMed ID: 17873605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Liver cirrhosis in diabetes mellitus; a complication not always recognized].
    Thewissen CM; Tiebosch AT; Kloppenburg WD; Haagsmna EB; Hoogenberg K
    Ned Tijdschr Geneeskd; 2008 Nov; 152(44):2369-74. PubMed ID: 19055132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.